Phase 2 study of MEDI4736 in patients with PD-L1+ locally advanced or metastatic stage IIIb-IV NSCLC treated with >= 2 prior regimens (ATLANTIC) Meeting Abstract
| Authors: | Garassino, M. C.; Barlesi, F.; Chaft, J.; Shi, K.; Ibrahim, R.; Stockman, P.; Ballas, M.; Rizvi, N. A. |
| Abstract Title: | Phase 2 study of MEDI4736 in patients with PD-L1+ locally advanced or metastatic stage IIIb-IV NSCLC treated with >= 2 prior regimens (ATLANTIC) |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | immunotherapy; nsclc; pd-l1; medi4736 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S429 |
| Language: | English |
| ACCESSION: | WOS:000370365102083 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30012-0 |
| Notes: | Meeting Abstract: P1.01-083 -- Source: Wos |
